Toronto Star: Mental illness is on the rise due to COVID-19. Could psychedelic be the ‘game changer’?
And amid the growing buzz around psychedelics, there’s been an exponential explosion in research into LSD, psilocybin, MDMA and ketamine to treat conditions such as depression, post-traumatic stress disorder (PTSD), anxiety and substance-use …